CDK inhibitor Senexin A, Purity ≥98%

Cat. No.: X24-05-ZQ818

CDK inhibitor Senexin A, Purity ≥98%

Synonym: 1366002-50-7; Senexin A; 4-(Phenethylamino)quinazoline-6-carbonitrile; CHEMBL4226806; 4-[(2-Phenylethyl)amino]-6-quinazolinecarbonitril; CDK inhibitor

  • CAS Number: 1366002-50-7
  • Compound CID: 56927063
Product Size
2 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Senexin A, soluble in DMSO and ethanol and insoluble in water, is an CDK kinase inhibitor that disrupts cell division processes. It targets CDK19 and CDK8.
Molecular Weight
274.32
Molecular Formula
C17H14N4
Targets
CDK19: 0.31 μM (Kd); CDK8: 0.83 μM (Kd)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 46 mg/mL (167.69 mM; Water: Insoluble; Ethanol: 46 mg/mL (167.69 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Senexin A can be used to study the inhibition of CDK8 and CDK19-mediated signaling pathways.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.